In Vitro Circuit Stability of 5-Fluorouracil and Oxaliplatin in Support of Hyperthermic Isolated Hepatic Perfusion
J Extra Corpor Technol, 42 1 (2010) 75-79
Published online: 2010-03-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
A phase 1 study of veliparib (ABT-888) plus weekly carboplatin and paclitaxel in advanced solid malignancies, with an expansion cohort in triple negative breast cancer (TNBC) (ETCTN 8620)
Monica K. Malhotra, Shalu Pahuja, Brian F. Kiesel, Leonard J. Appleman, Fei Ding, Yan Lin, Hussein A. Tawbi, Ronald G. Stoller, James J. Lee, Chandra P. Belani, Alice P. Chen, Vincent L. Giranda, Stacie Peacock Shepherd, Leisha A. Emens, S. Percy Ivy, Edward Chu, Jan H. Beumer and Shannon PuhallaBreast Cancer Research and Treatment 198 (3) 487 (2023)
https://doi.org/10.1007/s10549-023-06889-0
Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies
Leonard J. Appleman, Jan H. Beumer, Yixing Jiang, Yan Lin, Fei Ding, Shannon Puhalla, Leigh Swartz, Taofeek K. Owonikoko, R. Donald Harvey, Ronald Stoller, Daniel P. Petro, Hussein A. Tawbi, Athanassios Argiris, Sandra Strychor, Marie Pouquet, Brian Kiesel, Alice P. Chen, David Gandara, Chandra P. Belani, Edward Chu and Suresh S. RamalingamCancer Chemotherapy and Pharmacology 84 (6) 1289 (2019)
https://doi.org/10.1007/s00280-019-03960-w
A phase I pharmacokinetic study of intraperitoneal bortezomib and carboplatin in patients with persistent or recurrent ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study
Danielle A. Jandial, William E. Brady, Stephen B. Howell, Heather A. Lankes, Russell J. Schilder, Jan H. Beumer, Susan M. Christner, Sandra Strychor, Matthew A. Powell, Andrea R. Hagemann, Kathleen N. Moore, Joan L. Walker, Paul A. DiSilvestro, Linda R. Duska, Paula M. Fracasso and Don S. DizonGynecologic Oncology 145 (2) 236 (2017)
https://doi.org/10.1016/j.ygyno.2017.03.013
Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer – An NRG oncology/Gynecologic Oncology Group study
Vivian E. von Gruenigen, Helen Q. Huang, Jan H. Beumer, Heather A. Lankes, William Tew, Thomas Herzog, Arti Hurria, Robert S. Mannel, Tina Rizack, Lisa M. Landrum, Peter G. Rose, Ritu Salani, William H. Bradley, Thomas J. Rutherford, Robert V. Higgins, Angeles Alvarez Secord and Gini FlemingGynecologic Oncology 144 (3) 459 (2017)
https://doi.org/10.1016/j.ygyno.2016.11.033
A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis
Jennifer R. Eads, Jan H. Beumer, Lavinia Negrea, Julianne L. Holleran, Sandra Strychor and Neal J. MeropolCancer Chemotherapy and Pharmacology 77 (2) 333 (2016)
https://doi.org/10.1007/s00280-015-2939-9
Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer
Eve T. Rodler, Brenda F. Kurland, Melissa Griffin, Julie R. Gralow, Peggy Porter, Rosa F. Yeh, Vijayakrishna K. Gadi, Jamie Guenthoer, Jan H. Beumer, Larissa Korde, Sandra Strychor, Brian F. Kiesel, Hannah M. Linden, John A. Thompson, Elizabeth Swisher, Xiaoyu Chai, Stacie Shepherd, Vincent Giranda and Jennifer M. SpechtClinical Cancer Research 22 (12) 2855 (2016)
https://doi.org/10.1158/1078-0432.CCR-15-2137
Phase I and pharmacokinetic evaluation of the anti-telomerase agent KML-001 with cisplatin in advanced solid tumors
Martin J. Edelman, Rena Lapidus, Josephine Feliciano, Miroslav Styblo, Jan H. Beumer, Tao Liu and Jogarao GobbruCancer Chemotherapy and Pharmacology 78 (5) 959 (2016)
https://doi.org/10.1007/s00280-016-3148-x
Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrews
Julie L. Eiseman, Jan H. Beumer, Lora H. Rigatti, Sandra Strychor, Kelly Meyers, Samuel Dienel and Charles C. HornCancer Chemotherapy and Pharmacology 75 (1) 143 (2015)
https://doi.org/10.1007/s00280-014-2623-5
Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer
Taofeek K. Owonikoko, Guojing Zhang, Xingming Deng, Michael R. Rossi, Jeffrey M. Switchenko, Gregory H. Doho, Zhengjia Chen, Sungjin Kim, Sandy Strychor, Susan M. Christner, Jan Beumer, Chunyang Li, Ping Yue, Alice Chen, Gabriel L. Sica, Suresh S. Ramalingam, Jeanne Kowalski, Fadlo R. Khuri and Shi‐Yong SunCancer Medicine 3 (6) 1579 (2014)
https://doi.org/10.1002/cam4.317
A Phase I Trial of Isolated Hepatic Perfusion (IHP) Using 5-FU and Oxaliplatin in Patients with Unresectable Isolated Liver Metastases from Colorectal Cancer
D. Magge, A. H. Zureikat, D. L. Bartlett, M. P. Holtzman, H. A. Choudry, J. H. Beumer, J. F. Pingpank, J. L. Holleran, S. Strychor, D. E. Cunningham, H. L. Jones and H. J. ZehAnnals of Surgical Oncology 20 (7) 2180 (2013)
https://doi.org/10.1245/s10434-013-2960-3
Distribution of 5-fluorouracil between lymphocytes and blood plasma
M. A. StashkevychThe Ukrainian Biochemical Journal 85 (4) 94 (2013)
https://doi.org/10.15407/ubj85.04.094
1453 (2012)
https://doi.org/10.1016/B978-1-4377-1454-8.00089-8